(Q47272566)

13 January 2018

title

Impact of weight loss, appetite, and the inflammatory response on quality of life in gastrointestinal cancer patients (English)

1 reference

13 January 2018

0 references

1 reference

1 reference

O'Gorman P

1

1 reference

13 January 2018

McMillan DC

series ordinal

2

1 reference

13 January 2018

McArdle CS

series ordinal

3

1 reference

13 January 2018

publication date

1 January 1998

1 reference

13 January 2018

published in

Nutrition and Cancer

1 reference

13 January 2018

volume

32

1 reference

13 January 2018

issue

2

1 reference

13 January 2018

page(s)

76-80

1 reference

13 January 2018

Prognostic effect of weight loss prior to chemotherapy in cancer patients. Eastern Cooperative Oncology Group

cites work

1 reference

https://api.crossref.org/works/10.1080%2F01635589809514722

Multivariate analyses as aids to diagnosis and assessment of prognosis in gastrointestinal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635589809514722

Cytokines, the acute-phase response, and resting energy expenditure in cachectic patients with pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635589809514722

Effect of ibuprofen on the acute-phase response and protein metabolism in patients with cancer and weight loss.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635589809514722

The relationship between weight loss and interleukin 6 in non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635589809514722

Changes in nutritional status associated with unresectable pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635589809514722

Relationship between weight loss, reduction of body cell mass and inflammatory response in patients with cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635589809514722

The reproducibility of subjective appetite scores.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635589809514722

EuroQol--a new facility for the measurement of health-related quality of life

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635589809514722

The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635589809514722

The value of acute phase protein measurements in clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635589809514722

The interrelationship of weight loss, dietary intake, and quality of life in ambulatory patients with cancer of the lung, breast, and ovary

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635589809514722

Ibuprofen reduces energy expenditure and acute-phase protein production compared with placebo in pancreatic cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635589809514722

A pilot study of megestrol acetate and ibuprofen in the treatment of cachexia in gastrointestinal cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635589809514722

10.1080/01635589809514722

21 January 2018

Identifiers

DOI

1 reference

13 January 2018

1 reference

13 January 2018